Understanding the blood-brain barrier using gene and protein expression profiling technologies

Brain Research Reviews

Volumn 62, Issue 1, 2009, Pages 83-98

  Pottiez, Gwënaël ^a,b,c   Flahaut, Christophe ^a,b,c   Cecchelli, Roméo ^a,b,c   Karamanos, Yannis ^a,b,c  

^a UNIV LILLE   (France)

^b LBHE   (France)

^c IMPRT IFR114   (France)

Author keywords

BBB; Blood brain barrier; Cerebral endothelial cells; Endothelial cells; Genomics; Proteomics

Indexed keywords

BETA INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; COFILIN; CREATINE KINASE; CXCL9 CHEMOKINE; CYTOSOL AMINOPEPTIDASE; F ACTIN; FORMALDEHYDE DEHYDROGENASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE TRANSPORTER 1; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON BETA SERINE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MANNITOL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; PLASMINOGEN; PREALBUMIN; PROTEIN 14 3 3; RANTES; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNINDEXED DRUG;

BLOOD BRAIN BARRIER; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN MICROCIRCULATION; DEMENTIA; DISEASE MARKER; DRUG EFFICACY; ELECTROMAGNETIC FIELD; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; STROKE; VIRUS IMMUNITY;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; PROTEIN ARRAY ANALYSIS;

EID: 70449632297     PISSN: 01650173     EISSN: 18726321     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2009.09.004     Document Type: Review

References (102)

1. Abbott N.J., Ronnback L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7 (2006) 41-53
2. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 (2003) 198-207
3. Alexander J.S., Minagar A., Harper M., Robinson-Jackson S., Jennings M., and Smith S.J. Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b. J. Mol. Neurosci. 32 (2007) 169-178
4. Alt C., Duvefelt K., Franzén B., Yang Y., and Engelhardt B. Gene and protein expression profiling of the microvascular compartment in experimental autoimmune encephalomyelitis in C57Bl/6 and SJL mice. Brain Pathol. 15 (2005) 1-16
5. Baak J.P., Janssen E.A., Soreide K., and Heikkilae R. Genomics and proteomics-the way forward. Ann. Oncol. 16 Suppl. 2 (2005) ii30-ii44
6. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16 (2004) 1-13
7. Bartus R.T., Elliott P.J., Dean R.L., Hayward N.J., Nagle T.L., Huff M.R., Snodgrass P.A., and Blunt D.G. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp. Neurol. 142 (1996) 14-28
8. Baty J.D., and Robinson P.R. Single and multiple ion recording techniques for the analysis of diphenylhydantoin and its major metabolite in plasma. Biomed. Mass Spectrom. 4 (1977) 36-41
9. Begley D.J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. 104 (2004) 29-45
10. Bogatcheva N.V., and Verin A.D. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc. Res. 76 (2008) 202-207
11. Bohman S., Matsumoto T., Suh K., Dimberg A., Jakobsson L., Yuspa S., and Claesson-Welsh L. Proteomic analysis of vascular endothelial growth factor-induced endothelial cell differentiation reveals a role for chloride intracellular channel 4 (CLIC4) in tubular morphogenesis. J. Biol. Chem. 280 (2005) 42397-42404
12. Boveri M., Kinsner A., Berezowski V., Lenfant A.M., Draing C., Cecchelli R., Dehouck M.P., Hartung T., Prieto P., and Bal-Price A. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience 137 (2006) 1193-1209
13. Brillault J., Berezowski V., Cecchelli R., and Dehouck M.P. Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischaemia. J. Neurochem. 83 (2002) 807-817
14. Brown R.C., and Davis T.P. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke 33 (2002) 1706-1711
15. Calabria A.R., and Shusta E.V. Blood-brain barrier genomics and proteomics: elucidating phenotype, identifying disease targets and enabling brain drug delivery. Drug Discov. Today 11 (2006) 792-799
16. Calabria A.R., and Shusta E.V. A genomic comparison of in vivo and in vitro brain microvascular endothelial cells. J. Cereb. Blood Flow Metab. 28 (2008) 135-148
17. Calabria A.R., Weidenfeller C., Jones A.R., de Vries H.E., and Shusta E.V. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J. Neurochem. 97 (2006) 922-933
18. Campostrini N., Areces L.B., Rappsilber J., Pietrogrande M.C., Dondi F., Pastorino F., Ponzoni M., and Righetti P.G. Spot overlapping in two-dimensional maps: a serious problem ignored for much too long. Proteomics 5 (2005) 2385-2395
19. Cecchelli R., Berezowski V., Lundquist S., Culot M., Renftel M., Dehouck M.P., and Fenart L. Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 6 (2007) 650-661
20. Chappa A.K., Cooper J.D., Audus K.L., and Lunte S.M. Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS. J. Pharm. Biomed. Anal. 43 (2007) 1409-1415
21. Chaudhuri A., Yang B., Gendelman H.E., Persidsky Y., and Kanmogne G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111 (2008) 2062-2072
22. Cucullo L., Marchi N., Marroni M., Fazio V., Namura S., and Janigro D. Blood-brain barrier damage induces release of alpha2-macroglobulin. Mol. Cell Proteomics 2 (2003) 234-241
23. Dallasta L.M., Pisarov L.A., Esplen J.E., Werley J.V., Moses A.V., Nelson J.A., and Achim C.L. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155 (1999) 1915-1927
24. de Vries H.E., Blom-Roosemalen M.C., van Oosten M., de Boer A.G., van Berkel T.J., Breimer D.D., and Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64 (1996) 37-43
25. Dehouck M.P., Meresse S., Delorme P., Fruchart J.C., and Cecchelli R. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J. Neurochem. 54 (1990) 1798-1801
26. Dehouck M.P., Jolliet-Riant P., Bree F., Fruchart J.C., Cecchelli R., and Tillement J.P. Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J. Neurochem. 58 (1992) 1790-1797
27. Deli M.A., Abraham C.S., Kataoka Y., and Niwa M. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell. Mol. Neurobiol. 25 (2005) 59-127
28. Diatchenko L., Lau Y.F., Campbell A.P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E.D., and Siebert P.D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 6025-6030
29. Dohgu S., Yamauchi A., Takata F., Naito M., Tsuruo T., Higuchi S., Sawada Y., and Kataoka Y. Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell. Mol. Neurobiol. 24 (2004) 491-497
30. Dombrowski S.M., Desai S.Y., Marroni M., Cucullo L., Goodrich K., Bingaman W., Mayberg M.R., Bengez L., and Janigro D. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia 42 (2001) 1501-1506
31. Donkin J.J., Turner R.J., Hassan I., and Vink R. Substance P in traumatic brain injury. Prog. Brain Res. 161 (2007) 97-109
32. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural. Transm. 113 (2006) 477-485
33. Fournier M.L., Gilmore J.M., Martin-Brown S.A., and Washburn M.P. Multidimensional separations-based shotgun proteomics. Chem. Rev. 107 (2007) 3654-3686
34. Franke H., Streckert J., Bitz A., Goeke J., Hansen V., Ringelstein E.B., Nattkamper H., Galla H.J., and Stogbauer F. Effects of Universal Mobile Telecommunications System (UMTS) electromagnetic fields on the blood-brain barrier in vitro. Radiat. Res. 164 (2005) 258-269
35. Franzén B., Duvefelt K., Jonsson C., Engelhardt B., Ottervald J., Wickman M., Yang Y., and Schuppe-Koistinen I. Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha. Brain Res. Mol. Brain Res. 115 (2003) 130-146
36. Ge S., Song L., and Pachter J.S. Where is the blood-brain barrier really?. J. Neurosci. Res. 79 (2005) 421-427
37. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17 (1999) 994-999
38. Haqqani A.S., Nesic M., Preston E., Baumann E., Kelly J., and Stanimirovic D. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J. 19 (2005) 1809-1821
39. Haqqani A.S., Kelly J., Baumann E., Haseloff R.F., Blasig I.E., and Stanimirovic D.B. Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J. Proteome Res. 6 (2007) 226-239
40. Haseloff R.F., Krause E., Bigl M., Mikoteit K., Stanimirovic D., and Blasig I.E. Differential protein expression in brain capillary endothelial cells induced by hypoxia and posthypoxic reoxygenation. Proteomics 6 (2006) 1803-1809
41. Hawkins B.T., and Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57 (2005) 173-185
42. Hoheisel D., Nitz T., Franke H., Wegener J., Hakvoort A., Tilling T., and Galla H.J. Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem. Biophys. Res. Commun. 244 (1998) 312-316
43. Hutamekalin P., Farkas A.E., Orbok A., Wilhelm I., Nagyoszi P., Veszelka S., Deli M.A., Buzas K., Hunyadi-Gulyas E., Medzihradszky K.F., Meksuriyen D., and Krizbai I.A. Effect of nicotine and polyaromatic hydrocarbons on cerebral endothelial cells. Cell Biol. Int. 32 (2008) 198-209
44. Kallmann B.A., Wagner S., Hummel V., Buttmann M., Bayas A., Tonn J.C., and Rieckmann P. Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J. 16 (2002) 589-591
45. Kamiie J., Ohtsuki S., Iwase R., Ohmine K., Katsukura Y., Yanai K., Sekine Y., Uchida Y., Ito S., and Terasaki T. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm. Res. 25 (2008) 1469-1483
46. Kanmogne G.D., Kennedy R.C., and Grammas P. HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. J. Neuropathol. Exp. Neurol. 61 (2002) 992-1000
47. Kanner A.A., Marchi N., Fazio V., Mayberg M.R., Koltz M.T., Siomin V., Stevens G.H., Masaryk T., Aumayr B., Vogelbaum M.A., Barnett G.H., and Janigro D. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97 (2003) 2806-2813
48. Kapural M., Krizanac-Bengez L., Barnett G., Perl J., Masaryk T., Apollo D., Rasmussen P., Mayberg M.R., and Janigro D. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res. 940 (2002) 102-104
49. Kraus J., Ling A.K., Hamm S., Voigt K., Oschmann P., and Engelhardt B. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann. Neurol. 56 (2004) 192-205
50. Lai C.H., Kuo K.H., and Leo J.M. Critical role of actin in modulating BBB permeability. Brain Res. Brain Res. Rev. 50 (2005) 7-13
51. Lapierre L.A., Tuma P.L., Navarre J., Goldenring J.R., and Anderson J.M. VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. J. Cell. Sci. 112 Pt 21 (1999) 3723-3732
52. Lasbennes F., Lacombe P., and Seylaz J. Effect of monoamine oxidase inhibition on the regional cerebral blood flow response to circulating noradrenaline. Brain Res. 454 (1988) 205-211
53. Lawrenson J.G., Reid A.R., Finn T.M., Orte C., and Allt G. Cerebral and pial microvessels: differential expression of gamma-glutamyl transpeptidase and alkaline phosphatase. Anat. Embryol. (Berl) 199 (1999) 29-34
54. Liu L.B., Xue Y.X., Liu Y.H., and Wang Y.B. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin\ cytoskeleton. J. Neurosci. Res. 86 (2008) 1153-1168
55. Lu C., Pelech S., Zhang H., Bond J., Spach K., Noubade R., Blankenhorn E.P., and Teuscher C. Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J. Neurosci. Res. 86 (2008) 2624-2640
56. Lu L., Yang P.Y., Rui Y., Kang H., Zhang J., Zhang J.P., and Feng W.H. Comparative proteome analysis of rat brain and coronary microvascular endothelial cells. Physiol. Res. 56 (2007) 159-168
57. Marchi N., Fazio V., Cucullo L., Kight K., Masaryk T., Barnett G., Vogelbaum M., Kinter M., Rasmussen P., Mayberg M.R., and Janigro D. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J. Neurosci. 23 (2003) 1949-1955
58. Marchi N., Rasmussen P., Kapural M., Fazio V., Kight K., Mayberg M.R., Kanner A., Ayumar B., Albensi B., Cavaglia M., and Janigro D. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor. Neurol. Neurosci. 21 (2003) 109-121
59. Marchi N., Cavaglia M., Fazio V., Bhudia S., Hallene K., and Janigro D. Peripheral markers of blood-brain barrier damage. Clin. Chim. Acta 342 (2004) 1-12
60. Martinez-Estrada O.M., Villa A., Breviario F., Orsenigo F., Dejana E., and Bazzoni G. Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J. Biol. Chem. 276 (2001) 9291-9296
61. Miller F., Fenart L., Landry V., Coisne C., Cecchelli R., Dehouck M.P., and Buee-Scherrer V. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model. Eur. J. Neurosci. 22 (2005) 835-844
62. Miller I., Crawford J., and Gianazza E. Protein stains for proteomic applications: which, when, why?. Proteomics 6 (2006) 5385-5408
63. Moron J.A., and Devi L.A. Use of proteomics for the identification of novel drug targets in brain diseases. J. Neurochem. 102 (2007) 306-315
64. Munir S., Singh S., Kaur K., and Kapur V. Suppression subtractive hybridization coupled with microarray analysis to examine differential expression of genes in virus infected cells. Biol. Proced. Online 6 (2004) 94-104
65. Nakagawa S., Deli M.A., Kawaguchi H., Shimizudani T., Shimono T., Kittel A., Tanaka K., and Niwa M. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 54 (2009) 253-263
66. Nylund R., and Leszczynski D. Proteomics analysis of human endothelial cell line EA.hy926 after exposure to GSM 900 radiation. Proteomics 4 (2004) 1359-1365
67. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250 (1975) 4007-4021
68. Ohtsuki S., and Terasaki T. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res. 24 (2007) 1745-1758
69. Ong S.E., and Mann M. Stable isotope labeling by amino acids in cell culture for quantitative proteomics. Methods Mol. Biol. 359 (2007) 37-52
70. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., and Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1 (2002) 376-386
71. Padieu P., and Maume B.F. Enzymatic activity assays in the hepatic cell by mass fragmentography associated with gas-liquid chromatography. Ann. Biol. Clin. (Paris). 34 (1976) 63-77
72. Pan W., Banks W.A., Fasold M.B., Bluth J., and Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37 (1998) 1553-1561
73. Pellieux C., Desgeorges A., Pigeon C.H., Chambaz C., Yin H., Hayoz D., and Silacci P. Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J. Biol. Chem. 278 (2003) 29136-29144
74. Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H., and Hidalgo J. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25 (1999) 343-357
75. Perriere N., Demeuse P., Garcia E., Regina A., Debray M., Andreux J.P., Couvreur P., Scherrmann J.M., Temsamani J., Couraud P.O., Deli M.A., and Roux F. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J. Neurochem. 93 (2005) 279-289
76. Perriere N., Yousif S., Cazaubon S., Chaverot N., Bourasset F., Cisternino S., Decleves X., Hori S., Terasaki T., Deli M., Scherrmann J.M., Temsamani J., Roux F., and Couraud P.O. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res. 1150 (2007) 1-13
77. Phanstiel D., Unwin R., McAlister G.C., and Coon J.J. Peptide quantification using 8-plex isobaric tags and electron transfer dissociation tandem mass spectrometry. Anal. Chem. 81 (2009) 1693-1698
78. Pottiez G., Sevin E., Cecchelli R., Karamanos Y., and Flahaut C. Actin, gelsolin and filamin-A are dynamic actors in the cytoskeleton remodelling contributing to the blood brain barrier phenotype. Proteomics 9 (2009) 1207-1219
79. Reese T.S., and Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34 (1967) 207-217
80. Revest P.A., Abbott N.J., and Gillespie J.I. Receptor-mediated changes in intracellular [Ca2+] in cultured rat brain capillary endothelial cells. Brain Res. 549 (1991) 159-161
81. Ricardo-Dukelow M., Kadiu I., Rozek W., Schlautman J., Persidsky Y., Ciborowski P., Kanmogne G.D., and Gendelman H.E. HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J. Neuroimmunol. 185 (2007) 37-46
82. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., Purkayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., Jacobson A., and Pappin D.J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3 (2004) 1154-1169
83. Roux F., Durieu-Trautmann O., Chaverot N., Claire M., Mailly P., Bourre J.M., Strosberg A.D., and Couraud P.O. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J. Cell. Physiol. 159 (1994) 101-113
84. Sanger F., Air G.M., Barrell B.G., Brown N.L., Coulson A.R., Fiddes C.A., Hutchison C.A., Slocombe P.M., and Smith M. Nucleotide sequence of bacteriophage phi X174 DNA. Nature 265 (1977) 687-695
85. Sato Y. Role of aminopeptidase in angiogenesis. Biol. Pharm. Bull. 27 (2004) 772-776
86. Shen Q., Goderie S.K., Jin L., Karanth N., Sun Y., Abramova N., Vincent P., Pumiglia K., and Temple S. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304 (2004) 1338-1340
87. Shusta E.V. Blood-brain barrier genomics, proteomics, and new transporter discovery. NeuroRx 2 (2005) 151-161
88. Stanness K.A., Neumaier J.F., Sexton T.J., Grant G.A., Emmi A., Maris D.O., and Janigro D. A new model of the blood-brain barrier: co-culture of neuronal, endothelial and glial cells under dynamic conditions. NeuroReport 10 (1999) 3725-3731
89. Suginta W., Karoulias N., Aitken A., and Ashley R.H. Chloride intracellular channel protein CLIC4 (p64H1) binds directly to brain dynamin I in a complex containing actin, tubulin and 14-3-3 isoforms. Biochem. J. 359 (2001) 55-64
90. Toborek M., Lee Y.W., Pu H., Malecki A., Flora G., Garrido R., Hennig B., Bauer H.C., and Nath A. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J. Neurochem. 84 (2003) 169-179
91. Trickler W.J., Mayhan W.G., and Miller D.W. Brain microvessel endothelial cell responses to tumor necrosis factor-alpha involve a nuclear factor kappa B (NF-kappaB) signal transduction pathway. Brain Res. 1048 (2005) 24-31
92. Unlu M., Morgan M.E., and Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 (1997) 2071-2077
93. Utepbergenov D.I., Mertsch K., Sporbert A., Tenz K., Paul M., Haseloff R.F., and Blasig I.E. Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Lett. 424 (1998) 197-201
94. Velculescu V.E., Zhang L., Vogelstein B., and Kinzler K.W. Serial analysis of gene expression. Science 270 (1995) 484-487
95. Vogelbaum M.A., Masaryk T., Mazzone P., Mekhail T., Fazio, McCartney S., Marchi N., Kanner A., and Janigro D. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage. Cancer 104 (2005) 817-824
96. Washburn M.P., Wolters D., and Yates III J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19 (2001) 242-247
97. Watt S.A., Patschkowski T., Kalinowski J., and Niehaus K. Qualitative and quantitative proteomics by two-dimensional gel electrophoresis, peptide mass fingerprint and a chemically-coded affinity tag (CCAT). J. Biotechnol. 106 (2003) 287-300
98. Wiener M.C., Sachs J.R., Deyanova E.G., and Yates N.A. Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures. Anal. Chem. 76 (2004) 6085-6096
99. Wilkins M.R., Pasquali C., Appel R.D., Ou K., Golaz O., Sanchez J.C., Yan J.X., Gooley A.A., Hughes G., Humphery-Smith I., Williams K.L., and Hochstrasser D.F. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (NY) 14 (1996) 61-65
100. Witt K.A., Mark K.S., Huber J., and Davis T.P. Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J. Neurochem. 92 (2005) 203-214
101. Zhang W., Mojsilovic-Petrovic J., Andrade M.F., Zhang H., Ball M., and Stanimirovic D.B. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 17 (2003) 2085-2087
102. Zhu D.Y., Li R., Liu G.Q., and Hua W.Y. Tumor necrosis factor alpha enhances the cytotoxicity induced by nitric oxide in cultured cerebral endothelial cells. Life Sci. 66 (2000) 1325-1335